Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma
NEUROENDOCRINOLOGY LETTERS
Poljakova, J; Hrebackova, J; Dvorakova, M; Moserova, M; Eskschlager, T; Hrabeta, J; Gottlicherova, M; Kopejtkova, B; Frei, E; Kizek, R; Stiborova, M, 2011: Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. NEUROENDOCRINOLOGY LETTERS 32, p. 101 - 116
Research Groups: